MiRNA-based therapy for Pulmonary Hypertension: MiRNA-5481 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, 21.46

MiRNA-based therapy for Pulmonary Hypertension: MiRNA-5481 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, 21.46

MiRNA-based therapy for Pulmonary Hypertension: MiRNA-5481 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, 21.46 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Pulmonary Hypertension: MiRNA-5481 inhibits pulmonary hypertension via down regulation of its target genes, 17/January/2015, 21.46, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that miRNA-5481, by increasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “MiRNA-5481 or its activators”  may be used to treat pulmonary hypertension.

Amount: $ 300

Undisclosed information: How MiRNA-5481 inhibits the development of pulmonary hypertension

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org